Partner Beth Jacob spoke on a panel on October 22, 2014 titled “A View on Pharmaceutical Patents in the BRICS World,” at the annual conference of the International Bar Association in Tokyo, Japan. The session examined how pharmaceutical patents are treated in BRICS (and emerging) economies and what, if anything, should be done to deal with these competing interests of pharmaceutical companies and generic manufacturers in these countries.